Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag
Seeking Alpha News (Sun, 15-Mar 9:30 AM ET)
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Wed, 4-Mar 3:00 AM ET)
ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
Globe Newswire (Mon, 23-Feb 8:00 PM ET)
Newsfile (Wed, 11-Feb 6:50 PM ET)
Globe Newswire (Mon, 9-Feb 2:16 PM ET)
PRNewswire (Mon, 9-Feb 3:02 AM ET)
Market Chameleon (Thu, 5-Feb 2:14 AM ET)
Globe Newswire (Thu, 5-Feb 3:00 AM ET)
Newsfile (Wed, 4-Feb 4:15 PM ET)
Newsfile (Tue, 3-Feb 4:10 PM ET)
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
Alvotech - trades on the NASDAQ stock market under the symbol ALVO.
As of March 17, 2026, ALVO stock price climbed to $3.82 with 384,384 million shares trading.
ALVO has a beta of 1.19, meaning it tends to be more sensitive to market movements. ALVO has a correlation of 0.12 to the broad based SPY ETF.
ALVO has a market cap of $1.20 billion. This is considered a Small Cap stock.
Last quarter Alvotech - reported $114 million in Revenue and -$.02 earnings per share. This fell short of revenue expectation by $-9 million and missed earnings estimates by -$.04.
In the last 3 years, ALVO traded as high as $18.00 and as low as $3.45.
The top ETF exchange traded funds that ALVO belongs to (by Net Assets): IBB, IDNA, PRFZ, IBBQ, BIB.
ALVO has underperformed the market in the last year with a price return of -66.2% while the SPY ETF gained +20.5%. ALVO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.2% and -3.5%, respectively, while the SPY returned -0.9% and -2.3%, respectively.
ALVO support price is $3.44 and resistance is $3.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALVO shares will trade within this expected range on the day.
